|
Video: What is a Stock Split?
|
|
Organovo Holdings is a biotechnology company that focuses on building 3D tissues that recapitulate primary aspects of human disease. Co. uses these models to identify gene targets responsible for driving the disease and initiates drug discovery programs around these validated targets. Co.'s NovoGen Bioprinters® are automated devices that enable the fabrication of 3D living tissues comprised of mammalian cells. Co.'s NovoGen Bioprinters® can also dispense pure hydrogel formulations, provided the physical properties of the hydrogel are compatible with the dispensing parameters. Co.'s NovoGen Bioprinters® also serve as components of its tissue prototyping and manufacturing platform. According to our ONVO split history records, Organovo Holdings has had 1 split. | |
|
Organovo Holdings (ONVO) has 1 split in our ONVO split history database. The split for ONVO took place on August 19, 2020. This was a 1 for 20 reverse split, meaning for each 20 shares of ONVO owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 50 share position following the split.
When a company such as Organovo Holdings conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the ONVO split history from start to finish, an original position size of 1000 shares would have turned into 50 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Organovo Holdings shares, starting with a $10,000 purchase of ONVO, presented on a split-history-adjusted basis factoring in the complete ONVO split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/24/2014 |
|
End date: |
04/22/2024 |
|
Start price/share: |
$122.20 |
|
End price/share: |
$1.03 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.16% |
|
Average Annual Total Return: |
-37.97% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$84.23 |
|
Years: |
10.00 |
|
|
|
Date |
Ratio |
08/19/2020 | 1 for 20 |
|
|